Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Cellectar Biosciences, Inc.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University of Southern California
GlaxoSmithKline
University of Arizona
UNC Lineberger Comprehensive Cancer Center
University of Wisconsin, Madison
AVM Biotechnology Inc
Centre Leon Berard
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University Medical Center Groningen